ORKA

Oruka Therapeutics, Inc. · NASDAQ

Sector Commercial Services
Industry Miscellaneous Commercial Services
Website -
Employees(FY) -
ISIN US6876041087

Performance

+1.01%

-22.91%

-27.22%

-22.33%

+69.04%

YTD

+56.17%

Profile

Advanced Technical Analysis

Technical Analysis of ORKA 2024-12-02

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 16 and the Technical Score at 28, both indicating weakness, while the Oscillators Score at 40 suggests a neutral stance. Overall, the combined scores point to a cautious outlook for the stock, highlighting potential challenges ahead.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ORKA

Stock Rank

Recent News & Updates

2024-11-19 08:00
Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference(GlobeNewswire)
2024-11-18 19:00
Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference(Globenewswire)
2024-11-13 16:25
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-11-13 03:25
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-11-04 07:00
Oruka Therapeutics to Present at Multiple November Investor Conferences(GlobeNewswire)
2024-11-03 18:00
Oruka Therapeutics to Present at Multiple November Investor Conferences(Globenewswire)
2024-09-25 07:08
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress(GlobeNewswire)
2024-09-24 19:08
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress(Globenewswire)
2024-09-12 07:05
Oruka Therapeutics Announces $200 Million Private Placement(GlobeNewswire)
2024-09-12 07:00
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19(GlobeNewswire)
2024-09-11 19:05
Oruka Therapeutics Announces $200 Million Private Placement(Globenewswire)
2024-09-11 19:00
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001's Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19(Globenewswire)
2024-09-03 07:00
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million(GlobeNewswire)
2024-09-02 19:00
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million(Globenewswire)
2024-08-29 04:50
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split(Globenewswire)
2024-08-26 07:30
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics(Globenewswire)
2024-08-23 04:30
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics(Globenewswire)
2024-08-16 04:15
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics(Globenewswire)
2024-08-01 04:15
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-06-27 14:16
Why Are Hedge Funds Shorting ARCA Biopharma, Inc. (ABIO)?(Insidermonkey)
2024-06-26 11:08
What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are Shorting(Insidermonkey)
2024-05-14 01:48
3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally(Investorplace)
2024-04-25 09:55
ABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024(Investorplace)
2024-04-25 04:15
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-04-03 02:30
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?(Investorplace)
2024-04-03 00:00
Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details(Yahoo Finance)
2024-04-02 19:30
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement(Globenewswire)
2024-02-01 03:35
ARCA biopharma Announces 2023 Financial Results(Globenewswire)
2023-10-18 04:25
ARCA biopharma Announces Third Quarter 2023 Financial Results(Globenewswire)
2023-07-21 04:25
ARCA biopharma Announces Second Quarter 2023 Financial Results(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.